Stocks & ETFs

We still believe there is a bullish opportunity nearby for treasury bonds, although the support areas we identified in our September post failed to hold. The...

The stock market has been charging higher into year end. Then came the FED interest rate decision and comments. But a even a couple weeks...

In today’s video, we explore potential scenarios for the Nasdaq 100 ETF (NASDAQ:QQQ) through January 2025. While seasonal strength often boosts year-end performance, results...

While the NASDAQ 100 (NASDAQ:QQQ) and many of the Magnificent 7 stocks went on to make new highs, the S&P 500 Equal Weight ETF...

International equities have posted some excellent returns in 2024. But with such U.S. dominance, do many people know? The allocation decision for many investors to...

AbbVie Inc is a global biopharmaceutical company that specializes in the discovery, development, manufacturing, and marketing of advanced medicines. AbbVie focuses primarily on immunology, oncology, neuroscience, and virology treatments, and...

In a recent analysis of the current stock market, I stated: “But, unless the market continues to broaden, we can almost take the Mag 7...

The S&P 500 has shown a loss of upside momentum with its last rally higher off the early November low. There is still no sign...

While the Nasdaq 100 made new all-time highs today climbing over 20,000, all the Magnificent 7 stocks and investors cheered! And as they should. After...

As we embark on a four-year journey with President Trump at the helm of the world’s largest economy, there are both knowns and unknowns. Given...